B cells in renal transplantation: pathological aspects and therapeutic interventions

被引:7
|
作者
Barnett, Nicholas [1 ]
Dorling, Anthony [2 ]
Mamode, Nizam [1 ]
机构
[1] Guys Hosp, Guys & St Thomas NHS Fdn Trust, Renal Urol & Transplantat Directorate, London SE1 9RT, England
[2] Guys Hosp, Ctr Transplantat, MRC, Kings Coll London, London SE1 9RT, England
基金
英国医学研究理事会;
关键词
B-lymphocytes; Graft rejection; Humoral; Immunity; ANTIBODY-MEDIATED REJECTION; INTRAVENOUS IMMUNE GLOBULIN; ACUTE CELLULAR REJECTION; KIDNEY-TRANSPLANTATION; RITUXIMAB TREATMENT; PLASMA-CELL; PROTEASOME INHIBITION; ACTIVATING FACTOR; MULTIPLE-MYELOMA; HLA ANTIBODIES;
D O I
10.1093/ndt/gfq716
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
B cells are vital in renal transplantation. B2 cells are part of the adaptive immune system. Activated B cells mature into plasma cells or memory B cells: their life spans can be prolonged by niches. B cells have a wide variety of functions: antibody production, antigen presentation, cytokine production and shaping of the splenic architecture. These functions play a vital role in graft rejection, both T cell-mediated rejection and antibody-mediated rejection. Markers of B cell activity include intragraft B cell infiltration, C4d deposition and circulating donor-specific antibodies. Many therapeutic options target B cells or plasma cells. As greater understanding is gained of their appropriate use, and new agents are developed, we should see prolonged graft survival and reduced graft rejection.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 50 条
  • [21] Therapeutic apheresis in kidney transplantation: A review of renal transplant immunobiology and current interventions with apheresis medicine
    Nishio-Lucar, Angie
    Balogun, Rasheed A.
    Sanoff, Scott
    JOURNAL OF CLINICAL APHERESIS, 2013, 28 (01) : 56 - 63
  • [22] IMPACT AND CONTENT - THE 2 ASPECTS OF THERAPEUTIC INTERVENTIONS
    LANGE, A
    OMER, H
    PRAXIS DER PSYCHOTHERAPIE UND PSYCHOSOMATIK, 1991, 36 (03) : 117 - 131
  • [23] Alloreactive B Cells, but Not Alloantibody, Mark Renal Transplantation.
    Lynch, Raymond J.
    Punch, Jeffrey D.
    Cascalho, Marilia I.
    Platt, Jeffrey L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 402 - 402
  • [24] Apoptosis of B cells in the early period after renal transplantation
    Korczak-Kowalska, G
    Gerwatowska, D
    Górski, A
    Klosowska, D
    Bocian, K
    Wierzbicki, P
    Durlik, M
    Wyzgal, J
    Pawlowska, M
    Orlowska, A
    Paczek, L
    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 459 - 463
  • [25] PSEUDOMYXOMA PERITONEI: PATHOLOGICAL AND THERAPEUTIC ASPECTS OF 26 CASES
    Nesrine, M.
    Aloui, A.
    Hela, R.
    Ayadi, M.
    Chaiet, N.
    Allani, B.
    Raies, H.
    Mezlini, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 254 - 254
  • [26] Preface: Nitric Oxide and Cancer: Pathological and Therapeutic Aspects
    Rapozzi, Valentina
    Varchi, Greta
    CRITICAL REVIEWS IN ONCOGENESIS, 2016, 21 (5-6): : V - V
  • [27] PATHOLOGICAL DIAGNOSTIC AND THERAPEUTIC ASPECTS OF LEIOMYOSARCOMA OF STOMACH ARE DISCUSSED
    GENNARI, L
    PIZZOCARO, G
    TUMORI, 1968, 54 (03) : 255 - +
  • [28] Cystic nephroma in the adult: pathological aspects and therapeutic implications
    Derouiche, A.
    Ouni, A.
    Kourda, N.
    Hentati, H.
    Ben Slama, M. R.
    Chebil, M.
    PATHOLOGICA, 2007, 99 (06) : 446 - 449
  • [29] PINEAL PARENCHYMAL TUMORS - CLINICAL, PATHOLOGICAL, AND THERAPEUTIC ASPECTS
    SCHILD, SE
    SCHEITHAUER, BW
    SCHOMBERG, PJ
    HOOK, CC
    KELLY, PJ
    FRICK, L
    ROBINOW, JS
    BUSKIRK, SJ
    CANCER, 1993, 72 (03) : 870 - 880
  • [30] Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma
    Tang, Huayan
    Tang, Zhaohui
    Jiang, Yongjun
    Wei, Weisheng
    Lu, Jian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (04) : 218 - 224